• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多重危险因素干预试验。危险因素变化及死亡率结果。多重危险因素干预试验研究组。

Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.

出版信息

JAMA. 1982 Sep 24;248(12):1465-77.

PMID:7050440
Abstract

The Multiple Risk Factor Intervention Trial was a randomized primary prevention trial to test the effect of a multifactor intervention program on mortality from coronary heart disease (CHD) in 12,866 high-risk men aged 35 to 57 years. Men were randomly assigned either to a special intervention (SI) program consisting of stepped-care treatment for hypertension, counseling for cigarette smoking, and dietary advice for lowering blood cholesterol levels, or to their usual sources of health care in the community (UC). Over an average follow-up period of seven years, risk factor levels declined in both groups, but to a greater degree for the SI men. Mortality from CHD was 17.9 deaths per 1,000 in the SI group and 19.3 per 1,000 in the UC group, a statistically nonsignificant difference of 7.1% (90% confidence interval, -15% to 25). Total mortality rates were 41.2 per 1,000 (SI) and 40.4 per 1,000 (UC). Three possible explanations for these findings are considered: (1) the overall intervention program, under these circumstances, does not affect CHD mortality; (2) the intervention used does affect CHD mortality, but the benefit was not observed in this trial of seven years' average duration, with lower-than-expected mortality and with considerable risk factor change in the UC group; and (3) measures to reduce cigarette smoking and to lower blood cholesterol levels may have reduced CHD mortality within subgroups of the SI cohort, with a possibly unfavorable response to antihypertensive drug therapy in certain but not all hypertensive subjects. This last possibility was considered most likely, needs further investigation, and lends support to some preventive measures while requiring reassessment of others.

摘要

多重危险因素干预试验是一项随机初级预防试验,旨在测试多因素干预方案对12866名年龄在35至57岁的高危男性冠心病(CHD)死亡率的影响。男性被随机分配到一个特殊干预(SI)方案组,该方案包括对高血压进行分级护理治疗、对吸烟进行咨询以及对降低血液胆固醇水平进行饮食建议,或者分配到社区中他们通常的医疗保健机构(UC)。在平均七年的随访期内,两组的危险因素水平均有所下降,但SI组下降幅度更大。SI组冠心病死亡率为每1000人中有17.9人死亡,UC组为每1000人中有19.3人死亡,统计学上无显著差异,差异为7.1%(90%置信区间,-15%至25%)。总死亡率分别为每1000人中有41.2人(SI组)和每1000人中有40.4人(UC组)。对于这些结果有三种可能的解释:(1)在这种情况下,总体干预方案不影响冠心病死亡率;(2)所采用的干预措施确实影响冠心病死亡率,但在这项平均为期七年的试验中未观察到益处,UC组死亡率低于预期且危险因素有相当大的变化;(3)减少吸烟和降低血液胆固醇水平的措施可能在SI队列的亚组中降低了冠心病死亡率,某些但并非所有高血压患者对抗高血压药物治疗可能有不利反应。最后一种可能性被认为最有可能,需要进一步研究,它支持了一些预防措施,同时需要对其他措施进行重新评估。

相似文献

1
Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.多重危险因素干预试验。危险因素变化及死亡率结果。多重危险因素干预试验研究组。
JAMA. 1982 Sep 24;248(12):1465-77.
2
Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials.多重危险因素干预试验中的冠心病与全因死亡率:亚组研究结果及与其他试验的比较
Prev Med. 1985 May;14(3):293-311. doi: 10.1016/0091-7435(85)90058-1.
3
Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.多重危险因素干预试验中高血压参与者10.5年后的死亡率。
Circulation. 1990 Nov;82(5):1616-28. doi: 10.1161/01.cir.82.5.1616.
4
Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.多重危险因素干预试验中的冠心病死亡、非致死性急性心肌梗死及其他临床结局。多重危险因素干预试验研究组
Am J Cardiol. 1986 Jul 1;58(1):1-13. doi: 10.1016/0002-9149(86)90232-8.
5
Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.多重危险因素干预试验中的运动心电图与冠心病死亡率。多重危险因素干预试验研究组
Am J Cardiol. 1985 Jan 1;55(1):16-24. doi: 10.1016/0002-9149(85)90291-7.
6
Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk Factor Intervention Trial.多重危险因素干预试验中高血压男性的心电图异常与冠心病死亡率
Clin Invest Med. 1987 Nov;10(6):606-15.
7
Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.多重危险因素干预试验中的基线静息心电图异常、抗高血压治疗与死亡率。多重危险因素干预试验研究组
Am J Cardiol. 1985 Jan 1;55(1):1-15. doi: 10.1016/0002-9149(85)90290-5.
8
Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.多危险因素干预试验中基线危险因素与冠心病及总死亡率的关系。多危险因素干预试验研究组
Prev Med. 1986 May;15(3):254-73. doi: 10.1016/0091-7435(86)90045-9.
9
Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups. Multiple Risk Factor Intervention Trial.MRFIT研究中干预组和常规护理组参与者16年后的肺癌死亡率。多重危险因素干预试验。
Ann Epidemiol. 1997 Feb;7(2):125-36. doi: 10.1016/s1047-2797(96)00123-8.
10
Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups.多重危险因素干预试验(MRFIT)中的高血压管理。特殊干预组和常规护理组男性的六年干预结果。
Arch Intern Med. 1985 Jul;145(7):1191-9.

引用本文的文献

1
Group-delivered interventions for lowering blood pressure in hypertension: a systematic review and meta-analysis.用于降低高血压患者血压的群体干预措施:一项系统评价与荟萃分析
Br J Gen Pract. 2025 Mar 27;75(753):e266-e276. doi: 10.3399/BJGP.2023.0585. Print 2025 Apr.
2
Health-promotion interventions targeting multiple behaviors: A meta-analytic review of general and behavior-specific processes of change.促进健康的干预措施针对多种行为:一般和行为特定变化过程的元分析综述。
Psychol Bull. 2024 Jul;150(7):798-838. doi: 10.1037/bul0000427. Epub 2024 Jun 24.
3
The Lipid-Heart Hypothesis and the Keys Equation Defined the Dietary Guidelines but Ignored the Impact of -Fat and High Linoleic Acid Consumption.
脂质-心脏假说和关键方程定义了膳食指南,但忽略了 - 脂肪和高亚油酸消耗的影响。
Nutrients. 2024 May 11;16(10):1447. doi: 10.3390/nu16101447.
4
'Essential' arterial hypertension: time for a paradigm change.“必需”性高血压:是时候改变观念了。
J Hypertens. 2024 Aug 1;42(8):1298-1304. doi: 10.1097/HJH.0000000000003767. Epub 2024 May 8.
5
Chlorthalidone vs Hydrochlorothiazide for Hypertension Treatment After Myocardial Infarction or Stroke: A Secondary Analysis of a Randomized Clinical Trial.氯噻酮与氢氯噻嗪治疗心肌梗死后或中风后的高血压:一项随机临床试验的二次分析。
JAMA Netw Open. 2024 May 1;7(5):e2411081. doi: 10.1001/jamanetworkopen.2024.11081.
6
Effect of different forms of coconut on the lipid profile in normal free-living healthy subjects: A randomized controlled trial (Phase II).不同形式的椰子对正常自由生活的健康受试者血脂水平的影响:一项随机对照试验(II期)。
Glob Epidemiol. 2024 Feb 2;7:100138. doi: 10.1016/j.gloepi.2024.100138. eCollection 2024 Jun.
7
Interactions Between Depression, Alcohol Intake, and Smoking on the Risk of Acute Coronary Syndrome.抑郁症、酒精摄入和吸烟之间的相互作用对急性冠状动脉综合征风险的影响
Psychiatry Investig. 2024 Jan;21(1):1-8. doi: 10.30773/pi.2023.0245. Epub 2024 Jan 12.
8
A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia.一份关于血脂异常管理的约旦多学科共识声明。
J Clin Med. 2023 Jun 27;12(13):4312. doi: 10.3390/jcm12134312.
9
Elevated pulse pressure and cardiovascular risk associated in Spanish population attended in primary care: IBERICAN study.西班牙初级保健人群中脉压升高与心血管风险的相关性:伊比利亚研究
Front Cardiovasc Med. 2023 May 9;10:1090458. doi: 10.3389/fcvm.2023.1090458. eCollection 2023.
10
Historical Review of the Use of Relative Risk Statistics in the Portrayal of the Purported Hazards of High LDL Cholesterol and the Benefits of Lipid-Lowering Therapy.关于使用相对风险统计数据描述高LDL胆固醇的所谓危害及降脂治疗益处的历史回顾。
Cureus. 2023 May 1;15(5):e38391. doi: 10.7759/cureus.38391. eCollection 2023 May.